Health-care companies rose sharply, recouping some losses from earlier in the week.
UnitedHealth Group recouped 6% on Friday, but still lost almost one quarter of its value for the week after the abrupt departure of Chief Executive Andrew Witty, and revelation of a Department of Justice probe into alleged Medicare fraud.
Novo Nordisk shares slipped after the Danish obesity-drug maker said Chief Executive Lars Fruergaard Jorgensen, who has headed the Danish pharmaceutical company for eight years, would step aside.
Bayer is making another push to resolve lawsuits linking the popular weedkiller Roundup to cancer, while exploring a bankruptcy filing for its Monsanto agriculture business in case the settlement plan fails.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.